Evidence map›Paper›PMID 39077736›Full record

ArticleFrontiers in microbiology2024

Coexistence of a novel NDM-1-encoding MDR plasmid and an IMP-4-encoding IncN-IncU hybrid plasmid in a clinical isolate of

Na Liu, Biao Tang, Hui Wang, Xiangyang Chen, Peipei Wen, Zhaorui Wang, Xu Chen, Xiaobing Guo, Jianjun Gou, Yinsen Song

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Na Liu *Translational Medicine Research Center, Zhengzhou People's Hospital, The Fifth Clinical College of Henan University of Chinese Medicine, Zhengzhou, China.
Biao Tang *Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, China.
Hui WangTranslational Medicine Research Center, Zhengzhou People's Hospital, The Fifth Clinical College of Henan University of Chinese Medicine, Zhengzhou, China.
Xiangyang ChenDepartment of Laboratory Medicine, Zhengzhou People's Hospital, The Fifth Clinical College of Henan University of Chinese Medicine, Zhengzhou, China.
Peipei WenTranslational Medicine Research Center, Zhengzhou People's Hospital, The Fifth Clinical College of Henan University of Chinese Medicine, Zhengzhou, China.
Zhaorui WangTranslational Medicine Research Center, Zhengzhou People's Hospital, The Fifth Clinical College of Henan University of Chinese Medicine, Zhengzhou, China.
Xu ChenTranslational Medicine Research Center, Zhengzhou People's Hospital, The Fifth Clinical College of Henan University of Chinese Medicine, Zhengzhou, China.
Xiaobing GuoDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jianjun GouDepartment of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yinsen SongTranslational Medicine Research Center, Zhengzhou People's Hospital, The Fifth Clinical College of Henan University of Chinese Medicine, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To investigate the genetic characteristics and transmission mechanism of the NDM-1-, IMP-4-, and SHV-12-producing multidrug-resistant (MDR) clinical isolate, Methods: Results: Conclusion: To our knowledge, our study represents the first characterization of a ST22

Indexed as

blaIMP-4blaNDM-1Citrobacter freundiigenomicsMDR

Identifiers

PMID39077736
PMCPMC11285197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.